Chapter 1. Biomarkers in Precision Medicine Psychiatry Market – Scope & Methodology
1.1    Market Segmentation
1.2    Scope, Assumptions & Limitations
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
 Chapter 2. Biomarkers in Precision Medicine Psychiatry Market – Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
             2.2.1    Demand Side
             2.2.2    Supply Side
2.3    Attractive Investment Propositions
2.4    COVID-19 Impact Analysis
 Chapter 3. Biomarkers in Precision Medicine Psychiatry Market – Competition Scenario
3.1    Market Share Analysis & Company Benchmarking
3.2    Competitive Strategy & Development Scenario
3.3    Competitive Pricing Analysis
3.4    Supplier-Distributor Analysis
 Chapter 4. Biomarkers in Precision Medicine Psychiatry Market Entry Scenario
4.1    Regulatory Scenario
4.2    Case Studies – Key Start-ups
4.3    Customer Analysis
4.4    PESTLE Analysis
4.5    Porters Five Force Model
             4.5.1    Bargaining Power of Suppliers
             4.5.2    Bargaining Powers of Customers
             4.5.3    Threat of New Entrants
             4.5.4    Rivalry among Existing Players
             4.5.5    Threat of Substitutes
 Chapter 5. Biomarkers in Precision Medicine Psychiatry Market – Landscape
5.1    Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities
 Chapter 6. Biomarkers in Precision Medicine Psychiatry Market – By Type
6.1    Introduction/Key Findings   
6.2    Proteomic
6.3    Genetic
6.4    Metabolomic
6.5    Imaging
6.6    Others
6.7    Y-O-Y Growth trend Analysis By Type
6.8    Absolute $ Opportunity Analysis By Type, 2024-2030
 Chapter 7. Biomarkers in Precision Medicine Psychiatry Market – By Technology
7.1    Introduction/Key Findings   
7.2    Sequencing
7.3    PCR
7.4    Immunoassay
7.5    Microarray
7.6    Others
7.7    Y-O-Y Growth  trend Analysis By Technology
7.8    Absolute $ Opportunity Analysis By Technology, 2024-2030
 Chapter 8. Biomarkers in Precision Medicine Psychiatry Market –  By End-User
8.1    Introduction/Key Findings
8.2    Hospitals & Clinics
8.3    Research & Academic Institutions
8.4    Pharmaceuticals
8.5    Others
8.6    Y-O-Y Growth trend Analysis By End-User
8.7    Absolute $ Opportunity Analysis By End-User, 2024-2030
 Chapter 9. Biomarkers in Precision Medicine Psychiatry Market , By Geography – Market Size, Forecast, Trends & Insights
9.1    North America
             9.1.1    By Country
                          9.1.1.1    U.S.A.
                          9.1.1.2    Canada
                          9.1.1.3    Mexico
             9.1.2    By Type
             9.1.3    By Technology
             9.1.4    By End-User
             9.1.5    Countries & Segments - Market Attractiveness Analysis
9.2    Europe
             9.2.1    By Country
                          9.2.1.1    U.K
                          9.2.1.2    Germany
                          9.2.1.3    France
                          9.2.1.4    Italy
                          9.2.1.5    Spain
                          9.2.1.6    Rest of Europe
             9.2.2    By Type
             9.2.3    By Technology
             9.2.4    By End-User
             9.2.5    Countries & Segments - Market Attractiveness Analysis
9.3    Asia Pacific
             9.3.1    By Country
                          9.3.1.1    China
                          9.3.1.2    Japan
                          9.3.1.3    South Korea
                          9.3.1.4    India      
                          9.3.1.5    Australia & New Zealand
                          9.3.1.6    Rest of Asia-Pacific
             9.3.2    By Type
             9.3.3    By Technology
             9.3.4    By End-User
             9.3.5    Countries & Segments - Market Attractiveness Analysis
9.4    South America
             9.4.1    By Country
                          9.4.1.1    Brazil
                          9.4.1.2    Argentina
                          9.4.1.3    Colombia
                          9.4.1.4    Chile
                          9.4.1.5    Rest of South America
             9.4.2    By Type
             9.4.3    By Technology
             9.4.4    By End-User
             9.4.5    Countries & Segments - Market Attractiveness Analysis
9.5    Middle East & Africa
             9.5.1    By Country
                          9.5.1.1    United Arab Emirates (UAE)
                          9.5.1.2    Saudi Arabia
                          9.5.1.3    Qatar
                          9.5.1.4    Israel
                          9.5.1.5    South Africa
                          9.5.1.6    Nigeria
                          9.5.1.7    Kenya
                          9.5.1.8    Egypt
                          9.5.1.9    Rest of MEA
             9.5.2    By Type
             9.5.3    By Technology
             9.5.4    By End-User
             9.5.5    Countries & Segments - Market Attractiveness Analysis
 Chapter 10. Biomarkers in Precision Medicine Psychiatry Market – Company Profiles – (Overview, Product Portfolio, Financials, Strategies & Developments)
10.1    Alto Neuroscience
10.2    Feel Therapeutics
10.3    Kintsugi
10.4    Sonde Health
10.5    EVOCAL health
10.6    Ellipsis Health
10.7    Genomind
10.8    Quanterix Corporation